> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Oncology Panel to Reviw 4 Pediatric Study Plans
- URL: https://www.fdaweb.com/oncology-panel-to-reviw-4-pediatric-study-plans/
- Published: 2020-06-02T12:00:00.000Z
- Updated: 2026-09-14T16:16:44.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5146912

*Federal Register* notice: FDA has announced a 6/17-18 Oncologic Drugs Advisory Committee meeting through an online teleconferencing platform. On 6/17, Salarius Pharmaceuticals will present pediatric development plans for SP 2577, and Celgene will present similar plans for marizomib. Both investigational products are under development for an adult oncology indication. On 6/18, information from two companies will be presented about pediatric development plans for two products — Tessa Therapeutics’ CD30.CAR–T and Syndax Pharmaceuticals’ SNDX–5613\. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-06-02/pdf/2020-11883.pdf?ref=fdaweb.com).